Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases

Anti-PD-1 antibodies (Abs) are among the optimal adjuvant therapies for melanoma at high risk of recurrence, especially BRAF wild-type melanoma, but the anti-tumour effects of anti-PD-1 Abs in the adjuvant setting for acral melanoma have not been evaluated previously. The aim of this study was to an...

Descripción completa

Detalles Bibliográficos
Autores principales: MUTO, Yusuke, KAMBAYASHI, Yumi, KATO, Hiroshi, FUKUSHIMA, Satoshi, ITO, Takamichi, MAEKAWA, Takeo, FUJISAWA, Yasuhiro, YOSHINO, Koji, UCHI, Hiroshi, MATSUSHITA, Shigeto, YAMAMOTO, Yuki, AMAGAI, Ryo, OHUCHI, Kentaro, HASHIMOTO, Akira, FUJIMURA, Taku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631249/
https://www.ncbi.nlm.nih.gov/pubmed/35670329
http://dx.doi.org/10.2340/actadv.v102.678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631249/
https://www.ncbi.nlm.nih.gov/pubmed/35670329
http://dx.doi.org/10.2340/actadv.v102.678

Ejemplares similares